Literature DB >> 25543283

Increased production of intestinal immunoglobulins in Syntenin-1-deficient mice.

Kentaro Tamura1, Masashi Ikutani2, Taketoshi Yoshida3, Ayumi Tanaka-Hayashi4, Tsutomu Yanagibashi5, Ran Inoue4, Yoshinori Nagai5, Yuichi Adachi3, Toshio Miyawaki3, Kiyoshi Takatsu5, Hisashi Mori6.   

Abstract

Syntenin-1 is an intracellular PDZ protein that binds multiple proteins and regulates protein trafficking, cancer metastasis, exosome production, synaptic formation, and IL-5 signaling. However, the functions of Syntenin-1 have not yet been clearly characterized in detail, especially in vivo. In this study, we generated a Syntenin-1 knock out (KO) mouse strain and analyzed the role(s) of Syntenin-1 in IL-5 signaling, because the direct interaction of Syntenin-1 with the cytoplasmic domain of the IL-5 receptor α subunit and the regulation of IL-5 signaling by Syntenin-1 have been reported. Unexpectedly, the number of IL-5-responding cells was normal and the levels of fecal immunoglobulins were rather higher in the Syntenin-1 KO mice. We also found that IgA and IgM production of splenic B cells stimulated in vitro was increased in Syntenin-1 KO mice. In addition, we showed that a distribution of intestinal microbial flora was influenced in Syntenin-1 KO mice. Our data indicate that Syntenin-1 negatively regulates the intestinal immunoglobulin production and has a function to maintain the intestinal homeostasis in vivo. The analysis of Syntenin-1 KO mice may provide novel information on not only mucosal immunity but also other functions of Syntenin-1 such as cancer metastasis and neural development.
Copyright © 2014 The Authors. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  Antibodies; B cells; Knockout mice; Mucosal immunity; Syntenin-1

Mesh:

Substances:

Year:  2014        PMID: 25543283     DOI: 10.1016/j.imbio.2014.12.003

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  6 in total

1.  Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.

Authors:  Nara Tae; Suhyun Lee; Okwha Kim; Juhee Park; Sunghun Na; Jeong-Hyung Lee
Journal:  Oncotarget       Date:  2017-06-13

Review 2.  PDZ Domains as Drug Targets.

Authors:  Nikolaj R Christensen; Jelena Čalyševa; Eduardo F A Fernandes; Susanne Lüchow; Louise S Clemmensen; Linda M Haugaard-Kedström; Kristian Strømgaard
Journal:  Adv Ther (Weinh)       Date:  2019-04-24

3.  Syntenin-knock out reduces exosome turnover and viral transduction.

Authors:  Rudra Kashyap; Marielle Balzano; Benoit Lechat; Kathleen Lambaerts; Antonio Luis Egea-Jimenez; Frédérique Lembo; Joanna Fares; Sofie Meeussen; Sebastian Kügler; Anton Roebroek; Guido David; Pascale Zimmermann
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

Review 4.  MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.

Authors:  Swadesh K Das; Santanu Maji; Stephen L Wechman; Praveen Bhoopathi; Anjan K Pradhan; Sarmistha Talukdar; Devanand Sarkar; Joseph Landry; Chunqing Guo; Xiang-Yang Wang; Webster K Cavenee; Luni Emdad; Paul B Fisher
Journal:  Pharmacol Res       Date:  2020-02-13       Impact factor: 7.658

5.  Syntenin controls migration, growth, proliferation, and cell cycle progression in cancer cells.

Authors:  Rudra Kashyap; Bart Roucourt; Frederique Lembo; Joanna Fares; Ane Marcos Carcavilla; Audrey Restouin; Pascale Zimmermann; Rania Ghossoub
Journal:  Front Pharmacol       Date:  2015-10-21       Impact factor: 5.810

6.  Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.

Authors:  Swadesh K Das; Chunqing Guo; Anjan K Pradhan; Praveen Bhoopathi; Sarmistha Talukdar; Xue-Ning Shen; Luni Emdad; Mark A Subler; Jolene J Windle; Devanand Sarkar; Xiang-Yang Wang; Paul B Fisher
Journal:  Oncotarget       Date:  2016-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.